vbivaccines.com (VBIV) - מקדם חוב לטווח ארוך להון

The price visualization on GURU.Markets for VBI Vaccines Inc. (VBIV) displays metrics for the company developing vaccines for oncological diseases and hepatitis B, where the debt load is 0.00. The business is suffering from a lack of funds and weak drug sales. The enterprise's stability depends on the advancement of oncological developments and strict financial oversight. Success depends on government contracts and the inclusion of medications in official vaccination schedules.

Investors must filter out the credit risks of VBI Vaccines Inc. (VBIV) by assessing the stability of its financing structure. Technological leadership in developing vaccines on the eVLP platform provides the company with fundamental competitiveness. By analyzing the level of long-term debt-to-equity, we evaluate the share of liabilities with maturities exceeding one year relative to equity. This metric visualizes the actual trajectory of financial leverage without speculative noise. Comparing this indicator with revenue confirms the overall solvency of the business.